BES_Mark.jpg
Bragar Eagel & Squire, P.C. is Investigating Certain Officers and Directors of Akorn, Inc. (AKRX) and Encourages AKRX Investors to Contact the Firm
November 07, 2018 16:48 ET | Bragar Eagel & Squire
NEW YORK, Nov. 07, 2018 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C. is investigating potential claims against certain officers and directors of Akorn, Inc. (NASDAQ: AKRX). In a recent...
Shareholders Foundation
Lawsuit for Investors in shares of Akorn, Inc. (NASDAQ: AKRX) announced by Shareholders Foundation
June 04, 2018 09:10 ET | Shareholders Foundation, Inc.
SAN DIEGO, June 04, 2018 (GLOBE NEWSWIRE) -- The Shareholders Foundation, Inc. announces that a lawsuit is pending for certain investors in Akorn, Inc. (NASDAQ: AKRX) shares. Investors who...
AkornLogoSOLID_.jpg
Akorn Shareholders Vote to Approve Merger Agreement with Fresenius Kabi
July 19, 2017 16:30 ET | Akorn, Inc.
LAKE FOREST, Ill., July 19, 2017 (GLOBE NEWSWIRE) -- Akorn, Inc. (NASDAQ:AKRX), a leading specialty generic pharmaceutical company, announced that its shareholders, at a special meeting held earlier...
RL-green.jpg
SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Files Class Action Suit Against Akorn, Inc.
June 22, 2017 20:00 ET | Rigrodsky & Long, P.A.
WILMINGTON, Del., June 22, 2017 (GLOBE NEWSWIRE) -- Rigrodsky & Long, P.A.: Rigrodsky & Long, P.A. announces that it has filed a class action complaint in the United States District Court...
AkornLogoSOLID_.jpg
Akorn Appoints Greg Lawless as Chief Human Resources Officer
January 21, 2016 07:00 ET | Akorn, Inc.
LAKE FOREST, Ill., Jan. 21, 2016 (GLOBE NEWSWIRE) -- Akorn, Inc. (Nasdaq:AKRX), a leading specialty generic pharmaceutical company, today announced that Gregory P. Lawless joined Akorn as Chief...